Hilus cell tumor of the ovary and endometrial carcinoma

case-report public-domain-us
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-05 ⓘ

This case report describes a patient with concurrent ovarian hilus cell tumor and endometrial adenocarcinoma, noting that serum testosterone levels decreased following surgical removal of the tumor.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A case of hilus cell tumour of the ovary was found in a patient with adenocarcinoma of the endometrium, the sixth such case reported in the literature. Serum levels of estradiol-17beta, progesterone, and testosterone were measured before and after surgical removal of the tumor and after dexamethasone suppression in the postoperative period. Only testosterone appeared to be related to the presence of the hilus cell tumor; its levels decreased after removal of the tumor.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Endometriosis Leydig Cell Tumor Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma Aged Endometriosis Endometriosis Endometriosis Estradiol Estradiol Female Humans Leydig Cell Tumor Leydig Cell Tumor Leydig Cell Tumor Ovarian Neoplasms Ovarian Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
pubmed
last seen: 2026-05-14T05:58:53.789372+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine